| Bioactivity | Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy[1][2]. |
| Name | [Asp371]-Tyrosinase (369-377), human |
| CAS | 168650-46-2 |
| Sequence | Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val |
| Shortening | YMDGTMSQV |
| Formula | C42H66N10O16S2 |
| Molar Mass | 1031.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
[Asp371]-Tyrosinase (369-377), human
CAS: 168650-46-2 F: C42H66N10O16S2 W: 1031.16
Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targe
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.